BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21059866)

  • 1. Serum paraoxonase and arylesterase activities in metabolic syndrome in Zahedan, southeast Iran.
    Hashemi M; Kordi-Tamandani DM; Sharifi N; Moazeni-Roodi A; Kaykhaei MA; Narouie B; Torkmanzehi A
    Eur J Endocrinol; 2011 Feb; 164(2):219-22. PubMed ID: 21059866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-diabetic metabolic syndrome and obesity do not affect serum paraoxonase and arylesterase activities but do affect oxidative stress and inflammation.
    Tabur S; Torun AN; Sabuncu T; Turan MN; Celik H; Ocak AR; Aksoy N
    Eur J Endocrinol; 2010 Mar; 162(3):535-41. PubMed ID: 20022940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum paraoxonase/arylesterase activities in phenylketonuric patients on diet.
    Schulpis KH; Bartzeliotou A; Tsakiris S; Gounaris A; Papassotiriou I
    Eur J Clin Nutr; 2007 Jun; 61(6):803-8. PubMed ID: 17203019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strawberries Added to the Usual Diet Suppress Fasting Plasma Paraoxonase Activity and Have a Weak Transient Decreasing Effect on Cholesterol Levels in Healthy Nonobese Subjects.
    Zasowska-Nowak A; Nowak PJ; Bialasiewicz P; Prymont-Przyminska A; Zwolinska A; Sarniak A; Wlodarczyk A; Markowski J; Rutkowski KP; Nowak D
    J Am Coll Nutr; 2016 Jul; 35(5):422-35. PubMed ID: 26934671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal chronic hepatitis B virus is implicated with low neonatal paraoxonase/arylesterase activities.
    Schulpis KH; Barzeliotou A; Papadakis M; Rodolakis A; Antsaklis A; Papassotiriou I; Vlachos GD
    Clin Biochem; 2008 Mar; 41(4-5):282-7. PubMed ID: 18035058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative status and serum PON1 activity in beta-thalassemia minor.
    Selek S; Aslan M; Horoz M; Gur M; Erel O
    Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of paraoxonase and arylesterase activities in patients with irritable bowel syndrome.
    Oran M; Tulubas F; Mete R; Aydin M; Sarikaya HG; Gurel A
    J Pak Med Assoc; 2014 Jul; 64(7):820-2. PubMed ID: 25255593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonase and arylesterase activities in patients with cardiac syndrome X, and their relationship with oxidative stress markers.
    Gur M; Yildiz A; Demirbag R; Yilmaz R; Aslan M; Ozdogru I; Erel O
    Coron Artery Dis; 2007 Mar; 18(2):89-95. PubMed ID: 17301599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.
    Lakshman MR; Gottipati CS; Narasimhan SJ; Munoz J; Marmillot P; Nylen ES
    Metabolism; 2006 Sep; 55(9):1201-6. PubMed ID: 16919539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between serum paraoxonase and homocysteine thiolactonase activity, adipokines, and asymmetric dimethyl arginine concentrations in renal transplant patients.
    Locsey L; Seres I; Sztanek F; Harangi M; Padra J; Kovacs D; Fedor R; Asztalos L; Paragh G
    Transplant Proc; 2013; 45(10):3685-7. PubMed ID: 24314997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activity of paraoxonase and arylesterase in patients with osteomyelitis.
    Tekin Koruk S; Aksoy N; Hamidanoglu M; Karsen H; Unlu S; Bilinc H
    Scand J Clin Lab Invest; 2012 Nov; 72(7):513-7. PubMed ID: 22950624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraoxonase and arylesterase activities in untreated dipper and non-dipper hypertensive patients.
    Yildiz A; Gur M; Demirbag R; Yilmaz R; Akyol S; Aslan M; Erel O
    Clin Biochem; 2008 Jul; 41(10-11):779-84. PubMed ID: 18355454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of oxidative stress, the activities of paraoxonase and arylesterase in patients with subclinical hypothyroidism.
    Cebeci E; Alibaz-Oner F; Usta M; Yurdakul S; Erguney M
    J Investig Med; 2012 Jan; 60(1):23-8. PubMed ID: 21997314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paraoxonase phenotype distribution in a healthy Iranian population.
    Sepahvand F; Shafiei M; Ghaffari SM; Rahimi-Moghaddam P; Mahmoudian M
    Basic Clin Pharmacol Toxicol; 2007 Aug; 101(2):104-7. PubMed ID: 17651311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of serum paraoxonase activity and MDA concentrations in patients suffering with oral squamous cell carcinoma.
    Malik UU; Siddiqui IA; Hashim Z; Zarina S
    Clin Chim Acta; 2014 Mar; 430():38-42. PubMed ID: 24389054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum arylesterase and paraoxonase activities in patients with ovarian tumors.
    Michalak S; Szubert S; Moszynski R; Sajdak S; Szpurek D
    Taiwan J Obstet Gynecol; 2014 Dec; 53(4):490-3. PubMed ID: 25510689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of serum paraoxonase and arylesterase activities between iron deficiency anemia patients and chronic kidney disease patients with anemia.
    Okuturlar Y; Akalin N; Kaptanogullari OH; Guner NT; Yilmaz D; Gedikbasi A; Soyluk O; Mert M; Serin SO; Kocoglu H; Hursitoglu M; Kumbasar A
    Ren Fail; 2016 Jun; 38(5):781-6. PubMed ID: 27050633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of paraoxonase and arylesterase activities in patients with iron deficiency anemia.
    Aslan M; Kosecik M; Horoz M; Selek S; Celik H; Erel O
    Atherosclerosis; 2007 Apr; 191(2):397-402. PubMed ID: 16684543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of oxidative stress, the activities of paraoxonase and arylesterase in patients with subclinic hypothyroidism.
    Cebeci E; Oner FA; Usta M; Yurdakul S; Erguney M
    Acta Biomed; 2011 Dec; 82(3):214-22. PubMed ID: 22783718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic value of thiols, paraoxonase 1, arylesterase and oxidative balance in colorectal cancer in human.
    Bulbuller N; Eren E; Ellidag HY; Oner OZ; Sezer C; Aydin O; Yılmaz N
    Neoplasma; 2013; 60(4):419-24. PubMed ID: 23581414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.